• LinkedIn
  • Twitter
  • Instagram

Mark J. Field FRSB FIScT

Neuroscientist

30 years pharma experience to Head of R&D

Creating

precision-analgesics™

Founder Analgesic Innovation

untitled%20(7)_edited
mjf%20presenting_edited
mjf talk
 
image0 (8).jpeg

ABOUT

image4.jpeg

PROJECTS

image5.jpeg

RESEARCH

image3.jpeg

MEDIA

image1 (2).jpeg

CONTACT

 
image0 (8).jpeg

ABOUT

Back to Icons

Find out more about Analgesic Innovation (Ai)

Entrepreneur scientist with over 30 years’ experience developing new medicines in Neuroscience & Pain.

 

Unique expertise across both preclinical research & clinical development @ Pfizer, Parke-Davis, MSD & Grunenthal. 

 

Currently Founder/Owner of Analgesic Innovation (Ai).

 
image4.jpeg

PROJECTS

Back to Icons

Find out more about 

precision-analgesics™

Led the research that identified Gabapentin (Neurontin®) and Pregabalin (Lyrica®) as analgesics which generated peak annual revenues of over $5 Billion for Pfizer.

Associated with >30 compounds entering clinical trials.

Establishing NewCo developing precision-analgesics™.

 
image5.jpeg

RESEARCH

Back to Icons

Explore MyBlog 

for expert views on analgesic news

My Research is documented in over 100 full-length Manuscripts, Abstracts and Patents with over 4500 citations and h-index of 32. Link to published research.

Independent R&D/analgesic expert - International speaker.

 
image3.jpeg

MEDIA

Back to Icons

Owner/Developer of digital media to increase awareness of of chronic pain to reduce the YEARS patients are waiting just for a diagnosis.

PainLandscape.com & thepainparadox.com

Find out more about The Pain Landscape and how more awareness can help reduce patients time to diagnosis.

 
image1 (2).jpeg

CONTACT

Back to Icons

Contact me here

or on social media.

  • LinkedIn
  • Twitter
  • Instagram

Float back to top

©2020 markjfield.com